Close

Ratings by Baird (Brian Skorney)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/25/2022 VistaGen Therapeutics VTGN Downgrade Neutral
(Outperform)
0.15
(0.16)
6.67% Details
7/22/2022 VistaGen Therapeutics VTGN Downgrade Neutral
(Outperform)
1.07
(0.16)
-85.05% Details
2/10/2022 Sio Gene Therapies SIOX New Coverage Outperform
(N/A)
0.77
(0.28)
-63.64% Details
1/27/2022 Reneo Pharmaceuticals RPHM New Coverage Outperform
(N/A)
7.23
(3.40)
-52.97% Details
12/20/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
12/9/2021 Reata Pharmaceuticals RETA Downgrade Neutral
(Outperform)
54.42
(22.12)
-59.35% Details
12/6/2021 Reata Pharmaceuticals RETA Maintain Outperform
(N/A)
 
 
  Details
10/7/2021 Voyager Therapeutics VYGR Upgrade Outperform
(Neutral)
3.87
(5.57)
43.93% Details
9/24/2021 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
9/16/2021 Theravance Biopharma TBPH Maintain Neutral
(N/A)
 
 
  Details
8/24/2021 Theravance Biopharma TBPH Maintain Neutral
(N/A)
 
 
  Details
8/3/2021 Immunovant IMVT Downgrade Neutral
(Outperform)
10.46
(4.88)
-53.35% Details
6/8/2021 Biogen BIIB Upgrade Neutral
(Underperform)
286.14
(197.78)
-30.88% Details
5/20/2021 VistaGen Therapeutics VTGN New Coverage Outperform
(N/A)
2.34
(0.16)
-93.16% Details
2/26/2021 Voyager Therapeutics VYGR Downgrade Neutral
(Outperform)
6.59
(5.57)
-15.48% Details
2/23/2021 Vertex VRTX Upgrade Outperform
(Neutral)
207.02
(283.45)
36.92% Details
11/10/2020 Intercept Pharmaceuticals ICPT Upgrade Outperform
(Neutral)
28.15
(15.24)
-45.86% Details
10/8/2020 Regeneron Pharma REGN Maintain Neutral
(N/A)
 
 
  Details
9/8/2020 Albireo Pharma ALBO Maintain Outperform
(N/A)
 
 
  Details
9/1/2020 Aimmune Therapeutics AIMT Maintain Outperform
(N/A)
 
 
  Details
8/19/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
8/18/2020 Principia Biopharma PRNB Maintain Outperform
(N/A)
 
 
  Details
7/23/2020 Regeneron Pharma REGN Maintain Neutral
(N/A)
 
 
  Details
7/7/2020 BELLUS Health Inc. BLU Maintain Outperform
(N/A)
 
 
  Details
6/30/2020 Intercept Pharmaceuticals ICPT Downgrade Neutral
(Outperform)
77.49
(15.24)
-80.33% Details
6/29/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
6/25/2020 Mirum Pharamceuticals MIRM New Coverage Outperform
(N/A)
20.97
(22.40)
6.82% Details
6/24/2020 Albireo Pharma ALBO New Coverage Outperform
(N/A)
27.50
(18.73)
-31.89% Details
6/19/2020 Biogen BIIB Maintain Underperform
(N/A)
 
 
  Details
6/18/2020 Biogen BIIB Maintain Underperform
(N/A)
 
 
  Details
6/16/2020 Applied Therapeutics APLT Maintain Outperform
(N/A)
 
 
  Details
6/12/2020 Reata Pharmaceuticals RETA Maintain Outperform
(Outperform)
 
 
  Details
6/8/2020 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
5/22/2020 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
5/21/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
5/15/2020 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
5/6/2020 Regeneron Pharma REGN Maintain Neutral
(N/A)
 
 
  Details
4/29/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
4/24/2020 Principia Biopharma PRNB Maintain Outperform
(N/A)
 
 
  Details
4/23/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
4/17/2020 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
4/6/2020 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
4/3/2020 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
3/31/2020 Reata Pharmaceuticals RETA Maintain Outperform
(N/A)
 
 
  Details
3/31/2020 Immunovant IMVT Maintain Outperform
(N/A)
 
 
  Details
3/17/2020 Enanta Pharmaceuticals ENTA Upgrade Outperform
(Neutral)
53.93
(50.94)
-5.54% Details
3/2/2020 BELLUS Health Inc. BLU Maintain Outperform
(N/A)
 
 
  Details
2/26/2020 Regeneron Pharma REGN Downgrade Neutral
(Outperform)
425.38
(697.33)
63.93% Details
2/6/2020 Biogen BIIB Maintain Underperform
(N/A)
 
 
  Details
2/5/2020 Biogen BIIB Maintain Underperform
(N/A)
 
 
  Details
1/31/2020 Vertex VRTX Downgrade Neutral
(Outperform)
232.41
(283.45)
21.96% Details
1/31/2020 Amgen AMGN Downgrade Underperform
(Neutral)
227.15
(226.97)
-0.08% Details
1/23/2020 Biogen BIIB Maintain Underperform
(N/A)
 
 
  Details
1/10/2020 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
1/9/2020 Applied Therapeutics APLT Maintain Outperform
(N/A)
 
 
  Details
1/8/2020 Immunovant IMVT New Coverage Outperform
(N/A)
15.57
(4.88)
-68.66% Details
1/7/2020 Apellis Pharmaceuticals APLS Maintain Outperform
(N/A)
 
 
  Details
12/20/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
12/17/2019 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
12/2/2019 Biogen BIIB Downgrade Underperform
(Neutral)
303.35
(197.78)
-34.8% Details
11/25/2019 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
11/12/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
11/6/2019 Theravance Biopharma TBPH Upgrade Neutral
(Underperform)
17.03
(9.99)
-41.34% Details
11/5/2019 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
11/1/2019 Celgene CELG Downgrade Neutral
(Outperform)
107.17
(108.24)
1% Details
10/21/2019 Vertex VRTX Maintain Outperform
(N/A)
 
 
  Details
10/15/2019 Reata Pharmaceuticals RETA Maintain Outperform
(N/A)
 
 
  Details
10/11/2019 Aimmune Therapeutics AIMT Maintain Outperform
(N/A)
 
 
  Details
10/4/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
9/30/2019 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
9/18/2019 Aimmune Therapeutics AIMT Maintain Outperform
(N/A)
 
 
  Details
9/16/2019 Aimmune Therapeutics AIMT Maintain Outperform
(N/A)
 
 
  Details
9/9/2019 Amgen AMGN Maintain Neutral
(N/A)
 
 
  Details
9/9/2019 Aimmune Therapeutics AIMT Maintain Outperform
(N/A)
 
 
  Details
8/20/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
8/20/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
8/12/2019 Axovant Gene Therapies AXGT Upgrade Outperform
(Neutral)
6.61
(2.10)
-68.23% Details
8/7/2019 Assembly Biosciences ASMB Maintain Outperform
(N/A)
 
 
  Details
8/7/2019 Regeneron Pharma REGN Upgrade Outperform
(Neutral)
299.57
(697.33)
132.78% Details
7/30/2019 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
6/26/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
6/10/2019 Applied Therapeutics APLT New Coverage Outperform
(N/A)
9.10
(0.96)
-89.45% Details
6/6/2019 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
5/9/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
5/1/2019 Amgen AMGN Maintain Neutral
(N/A)
 
 
  Details
4/10/2019 Amgen AMGN Maintain Neutral
(N/A)
 
 
  Details
3/29/2019 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
3/28/2019 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
3/25/2019 Aimmune Therapeutics AIMT Maintain Outperform
(N/A)
 
 
  Details
3/21/2019 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
3/12/2019 Celgene CELG Maintain Outperform
(N/A)
 
 
  Details
2/22/2019 Voyager Therapeutics VYGR Maintain Outperform
(Outperform)
 
 
  Details
2/19/2019 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
2/14/2019 Aimmune Therapeutics AIMT Maintain Outperform
(N/A)
 
 
  Details
2/12/2019 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
2/12/2019 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
2/7/2019 Regeneron Pharma REGN Maintain Neutral
(N/A)
 
 
  Details
2/1/2019 Celgene CELG Maintain Outperform
(N/A)
 
 
  Details
1/4/2019 Celgene CELG Upgrade Outperform
(Neutral)
66.64
(108.24)
62.42% Details
12/12/2018 Neurocrine Bio. NBIX Maintain Outperform
(N/A)
 
 
  Details
12/7/2018 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
11/8/2018 Voyager Therapeutics VYGR Maintain Outperform
(N/A)
 
 
  Details
11/1/2018 Curis CRIS Maintain Outperform
(N/A)
 
 
  Details
10/25/2018 Biogen BIIB Maintain Neutral
(N/A)
 
 
  Details
10/9/2018 Principia Biopharma PRNB New Coverage Outperform
(N/A)
26.37
(100.05)
279.41% Details
9/26/2018 Reata Pharmaceuticals RETA Maintain Outperform
(N/A)
 
 
  Details
9/24/2018 Sarepta Therapeutics SRPT Maintain Outperform
(N/A)
 
 
  Details
9/12/2018 Gilead Sciences GILD Maintain Neutral
(N/A)
 
 
  Details
9/11/2018 Amgen AMGN Maintain Neutral
(N/A)
 
 
  Details
9/10/2018 Amgen AMGN Maintain Neutral
(N/A)
 
 
  Details